Advertisement

Topics

Roche builds confidence in I-O portfolio with positive kidney cancer data

10:24 EST 12 Dec 2017 | thePharmaLetter

Swiss oncology giant Roche has revealed positive results from the Phase III IMmotion151 study of Tecentriq…

Original Article: Roche builds confidence in I-O portfolio with positive kidney cancer data

NEXT ARTICLE

More From BioPortfolio on "Roche builds confidence in I-O portfolio with positive kidney cancer data"

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...